1[1]Tay, S. S., and W. C. Wong. Gracile nucleus of streptozotocin - induced diabetic rats. J. Neurocytol. 1991,20: 356 - 364.
2[2]Yorn Schmidt, Jurgen W. Unger, Ilse Bartke, et al. Effect of nerve growth favtor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Experimental Neurology. 1995,132:16 - 23.
3[3]M. A. Fahim, F. EL - Sabban, and N. Davidson. Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin - diabetic mice. The anatomical record. 1998,251: 240 - 244.
4[4]Robert E. Schmidt. The role of nerve growth factor in the pathogenesis and therapy of diabetic neuropathy. Diabet Med. 1993,10( suppl 2): 10 s - 13 s.
5[5]Said G., Slama G., Selva J., et al. Progressive centripetal degeneration of axons in small fibre diabetic neuropathy. Brain. 1983,106:791 -807.
6[6]Llewelyn J. G., Gilbey S. C. ,Thomas P. K., et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinicopathological study. Brain. 1991,114: 867 - 892.
7[7]R. A. Malik. The pathology of human diabetic neuropathy. Diabetes. 1997,46(suppl) :s 50 - s 53.
8[8]Pamela B. Jaffey and Benjamin B. Gelman. Increased vulnerability to demyelination in streptozotocin diabetic rats. The Journal of Comparative Neurology. 1996,373: 55 - 61.
9[9]Thomas, P. K., J. P. Fraher, et al. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of rat. Acta Neuropathol. 1990,79:375 - 386.
10[10]Scarpini E., Doronzo R., Baron P., et al. Phenotypic and proliferative properties of Schwann cells from nerves of diabetic patients. Int J Clin Pharmacol Res. 1992,12(5 - 6) :211 - 5.
4Biessels G S,Cristino N A,Rutten G J,et al.Neurophysiological changes in the centraland peripheral nervous system of streptozotocin diabetic rats.Course of development and effects of insulin treatment[J].Brain,1999,122(4):757.
5Biessels G J,van der Heide L P,Kamal A,et al.Ageing and diabetes:implication for brain function[J].Eur J Pharmacol,2002,1 (14):441.
6Arvanitakis Z,Wilson R S,Bienias J L,et al.,Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function[J].Arch Neurol,2004,61(5):661.
7Schechter R,Beju D,Miller K E.The effect of insulin deficiency on Tau and neurofilament in the insulin knockout mouse[J].Biochem Biophys Res Commun,2005,334(4):979.
8Feldman E L.Oxidative stress and diabetic neuropathy:a new understanding of an old problem[J].J Clin Invest,2003,111 (4):431.